Prices are in GBP and shown per vial as supplied, lyophilised, for in-vitro laboratory research only
The STEP-1 data at 68 weeks showed sustained lipid benefits without attenuation, suggesting the changes persist as long as treatment continues 1
Astragalus polysaccharide: implication for intestinal barrier, anti-inflammation, and animal production
Center for Drug Evaluation and Research (CDER), U.S
In appropriate patients, medically supervised GLP-1 therapy has been associated with: Sustained weight reduction over time Improvements in A1C and overall blood sugar in people with type 2 diabetes Reduced waist circumference and visceral fat Better blood pressure, cholesterol, and other metabolic markers In some studies with Wegovy, a reduced risk of certain serious cardiovascular events in adults with obesity and existing heart disease At NuIQ, the goal of our GLP-1 semaglutide program is not just fast weight lossits sustainable weight management, better energy, and long-term metabolic health, all under the guidance of licensed medical professionals
Lower doses are generally well-tolerated